Predictmedix AI Surpasses 500,000 Scans with Smart Health AI Stations
Predictmedix AI (CSE: PMED, OTC: PMEDF) has achieved a significant milestone with its Smart Health AI Stations completing over 500,000 individual scans. The company's non-invasive, AI-powered screening tools integrate advanced computer vision with adaptive machine learning to detect health risks including infectious disease symptoms, mental health indicators, and impairment in real-time.
The technology offers privacy-focused health insights and features rapid vitals screening and impairment detection capabilities. Dr. Rahul Kushwah, Chief Operating Officer, emphasized that the milestone demonstrates the trust earned and lives protected through their solution. The system's algorithms improve with each scan, enabling faster and more reliable interventions.
The company's Smart Health AI Stations are designed for deployment across healthcare, corporate, and public sectors, with expanding capabilities in mental health assessment, including detection of stress and fatigue. Predictmedix AI plans to strengthen industry partnerships and explore new opportunities in telemedicine and personalized analytics.
Predictmedix AI (CSE: PMED, OTC: PMEDF) ha raggiunto un traguardo significativo con le sue Smart Health AI Stations, che hanno completato oltre 500.000 scansioni individuali. Gli strumenti di screening non invasivi e basati sull'IA dell'azienda integrano una visione computerizzata avanzata con un apprendimento automatico adattivo per rilevare rischi per la salute, inclusi i sintomi di malattie infettive, indicatori di salute mentale e compromissioni in tempo reale.
La tecnologia offre approfondimenti sulla salute focalizzati sulla privacy e presenta capacità di screening rapidi dei parametri vitali e rilevamento delle compromissioni. Il Dr. Rahul Kushwah, Chief Operating Officer, ha sottolineato che questo traguardo dimostra la fiducia guadagnata e le vite protette grazie alla loro soluzione. Gli algoritmi del sistema migliorano con ogni scansione, consentendo interventi più rapidi e affidabili.
Le Smart Health AI Stations dell'azienda sono progettate per essere implementate nei settori sanitario, aziendale e pubblico, con capacità in espansione nella valutazione della salute mentale, inclusa la rilevazione di stress e affaticamento. Predictmedix AI prevede di rafforzare le partnership nel settore e esplorare nuove opportunità nella telemedicina e nell'analisi personalizzata.
Predictmedix AI (CSE: PMED, OTC: PMEDF) ha logrado un hito significativo con sus Smart Health AI Stations, que han completado más de 500,000 escaneos individuales. Las herramientas de detección no invasivas y basadas en IA de la empresa integran visión por computadora avanzada con aprendizaje automático adaptativo para detectar riesgos de salud, incluidos síntomas de enfermedades infecciosas, indicadores de salud mental y deterioro en tiempo real.
La tecnología ofrece información sobre la salud centrada en la privacidad y presenta capacidades de detección rápida de signos vitales y deterioro. El Dr. Rahul Kushwah, Director de Operaciones, enfatizó que este hito demuestra la confianza ganada y las vidas protegidas a través de su solución. Los algoritmos del sistema mejoran con cada escaneo, lo que permite intervenciones más rápidas y confiables.
Las Smart Health AI Stations de la empresa están diseñadas para su implementación en los sectores de salud, corporativo y público, con capacidades en expansión en la evaluación de la salud mental, incluida la detección de estrés y fatiga. Predictmedix AI planea fortalecer las asociaciones en la industria y explorar nuevas oportunidades en telemedicina y análisis personalizado.
Predictmedix AI (CSE: PMED, OTC: PMEDF)는 Smart Health AI Stations의 50만 개 이상의 개별 스캔을 완료하며 중요한 이정표를 달성했습니다. 이 회사의 비침습적이고 AI 기반의 선별 도구는 고급 컴퓨터 비전과 적응형 기계 학습을 통합하여 감염병 증상, 정신 건강 지표 및 실시간 손상을 포함한 건강 위험을 감지합니다.
이 기술은 개인 정보 보호에 중점을 둔 건강 통찰력을 제공하며 신속한 생체 신호 스크리닝 및 손상 감지 기능을 갖추고 있습니다. COO인 Rahul Kushwah 박사는 이 이정표가 그들의 솔루션을 통해 얻은 신뢰와 보호된 생명을 보여준다고 강조했습니다. 시스템의 알고리즘은 각 스캔마다 개선되어 더 빠르고 신뢰할 수 있는 개입을 가능하게 합니다.
회사의 Smart Health AI Stations는 의료, 기업 및 공공 부문에 배치되도록 설계되었으며, 스트레스 및 피로 감지를 포함한 정신 건강 평가에서의 기능이 확장되고 있습니다. Predictmedix AI는 산업 파트너십을 강화하고 원격 의료 및 개인화된 분석에서 새로운 기회를 탐색할 계획입니다.
Predictmedix AI (CSE: PMED, OTC: PMEDF) a atteint une étape significative avec ses Smart Health AI Stations, qui ont réalisé plus de 500 000 scans individuels. Les outils de dépistage non invasifs et basés sur l'IA de l'entreprise intègrent une vision par ordinateur avancée avec un apprentissage automatique adaptatif pour détecter les risques pour la santé, y compris les symptômes de maladies infectieuses, les indicateurs de santé mentale et les incapacités en temps réel.
La technologie offre des informations sur la santé axées sur la confidentialité et dispose de capacités de dépistage rapide des signes vitaux et de détection des incapacités. Le Dr. Rahul Kushwah, directeur des opérations, a souligné que cette étape démontre la confiance acquise et les vies protégées grâce à leur solution. Les algorithmes du système s'améliorent à chaque scan, permettant des interventions plus rapides et plus fiables.
Les Smart Health AI Stations de l'entreprise sont conçues pour être déployées dans les secteurs de la santé, des entreprises et du public, avec des capacités en expansion dans l'évaluation de la santé mentale, y compris la détection du stress et de la fatigue. Predictmedix AI prévoit de renforcer les partenariats industriels et d'explorer de nouvelles opportunités en télémédecine et en analyses personnalisées.
Predictmedix AI (CSE: PMED, OTC: PMEDF) hat einen bedeutenden Meilenstein erreicht, da seine Smart Health AI Stations über 500.000 individuelle Scans abgeschlossen haben. Die nicht-invasiven, KI-gestützten Screening-Tools des Unternehmens integrieren fortschrittliche Computer Vision mit adaptivem maschinellen Lernen, um Gesundheitsrisiken zu erkennen, einschließlich Symptomen von Infektionskrankheiten, Indikatoren für psychische Gesundheit und Beeinträchtigungen in Echtzeit.
Die Technologie bietet datenschutzorientierte Gesundheitsinformationen und verfügt über schnelle Vitalzeichen-Screening- und Beeinträchtigungserkennungsfunktionen. Dr. Rahul Kushwah, Chief Operating Officer, betonte, dass dieser Meilenstein das Vertrauen zeigt, das gewonnen wurde, und die Leben, die durch ihre Lösung geschützt wurden. Die Algorithmen des Systems verbessern sich mit jedem Scan, was schnellere und zuverlässigere Interventionen ermöglicht.
Die Smart Health AI Stations des Unternehmens sind für den Einsatz in den Bereichen Gesundheitswesen, Unternehmen und öffentliche Sektoren konzipiert, mit erweiterten Fähigkeiten in der Bewertung der psychischen Gesundheit, einschließlich der Erkennung von Stress und Müdigkeit. Predictmedix AI plant, die Partnerschaften in der Branche zu stärken und neue Möglichkeiten in der Telemedizin und personalisierten Analytik zu erkunden.
- Achieved significant milestone of 500,000 completed scans, demonstrating market adoption
- Technology improves continuously through machine learning with each scan
- Expanding capabilities into mental health assessment, broadening market potential
- Privacy-focused solution suitable for multiple sectors (healthcare, corporate, public)
- None.
Scalable Innovation Driving Change
The completion of 500,000 scans showcases the power of Predictmedix AI’s non-invasive, AI-powered screening tools, designed to deliver unmatched accuracy and efficiency. By integrating advanced computer vision with adaptive machine learning, the Smart Health AI Stations detect critical health risks—including infectious disease symptoms, mental health indicators, and impairment—in real time. With every scan, the system’s algorithms become sharper, enabling faster, more reliable interventions and fostering safer environments for organizations and communities worldwide.
Empowering Health and Well-Being
“Reaching 500,000 scans is more than a technological triumph—it’s a testament to the trust we’ve earned and the lives we’re helping protect,” said Dr. Rahul Kushwah, Chief Operating Officer of Predictmedix AI. “Our Smart Health AI Stations harness vast datasets to refine diagnostic precision, giving organizations the insights they need to act swiftly. As we push the boundaries of machine learning, we’re expanding our focus to address both physical and mental well-being, ensuring our solutions remain vital in today’s evolving health and safety landscape.”
Versatile Solutions for a Modern World
From rapid vitals screening to impairment detection, Predictmedix AI’s technology offers privacy-focused, actionable health insights with minimal disruption. Its growing mental health assessment capabilities are proving especially valuable, enabling employers to identify stress, fatigue —supporting employee well-being through proactive, data-driven care. This versatility makes the Smart Health AI Stations a game-changer across industries.
Looking Ahead
With this milestone, Predictmedix AI solidifies its position as a leader in AI-powered health innovation. The company is poised for continued growth, with plans to strengthen industry partnerships, integrate multimodal health data, and explore new frontiers in telemedicine and personalized analytics. As the demand surges for ethical, automated AI solutions, Predictmedix AI remains committed to advancing tools that prioritize safety, health, and well-being on a global scale.
To receive company news, please sign up for alerts at the bottom of the page link below: https://predictmedix.com/press-releases/
About Predictmedix AI Inc.
Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA:3QP) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations – powered by a proprietary artificial intelligence (AI) – use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedix AI’s proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.
Caution Regarding Forward-Looking Information:
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company’s securities have not been registered under the
All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.
Disclaimer: The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250407938533/en/
Dr. Rahul Kushwah, COO
rahul@predictmedix.com
(647) 889 6916
Source: Predictmedix AI Inc.